18 Jul 2017 10:35
18 July 2017
Omega Diagnostics Group plc
Result of General Meeting
Further to Omega's announcement of 30 June 2017, the Company is pleased to announce today the passing of the Resolutions at the General Meeting held earlier today. The Placing, Subscription and Open Offer remain conditional on Admission of the New Ordinary Shares to AIM which is expected to take place at 8.00 a.m. tomorrow.
With effect from Admission the Company will have 126,884,060 Ordinary Shares in issue, with no shares held in treasury. Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 30 June 2017.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director |
|
Jag Grewal, Group Sales and Marketing Director |
|
|
|
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/James Thompson (Corporate Finance) |
|
Mia Gardner (Corporate Broking) |
|
|
|
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | David Evans | ||||
2. | Reason for notification | |||||
b) | Position / status | Non-Executive Chairman | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument
Identification code
| ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 19 July 2017 | ||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Andrew Shepherd | ||||
2. | Reason for notification | |||||
b) | Position / status | Chief Executive Officer | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument
Identification code
| ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 19 July 2017 | ||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Kieron Harbinson | ||||
2. | Reason for notification | |||||
b) | Position / status | Finance Director | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument
Identification code
| ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 19 July 2017 | ||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Jag Grewal | ||||
2. | Reason for notification | |||||
b) | Position / status | Sales & Marketing Director | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument
Identification code
| ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 19 July 2017 | ||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Colin King | ||||
2. | Reason for notification | |||||
b) | Position / status | Chief Operating Officer | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument
Identification code
| ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 19 July 2017 | ||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||